US2019216863A1PendingUtilityA1
Methods of reducing incidence of mortality in fowl
Est. expiryApr 15, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A23K 10/18A61K 35/742A61K 2035/115A23K 50/75A61K 35/747A61K 9/0053A61K 9/0056A23K 10/16C12N 1/20A61K 35/741C12R 2001/225C12R 2001/07C12R 2001/01C12N 1/205
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure relates to methods for decreasing incidence of mortality in fowl through administering isolated microorganisms to the fowl. In particular aspects, the disclosure provides methods of decreasing incidence of mortality in fowl through administration of a Clostridium sp. and a Clostridium cluster XIV bacterium to the fowl. The disclosure further relates to isolated microorganisms and compositions comprising the same.
Claims
exact text as granted — not AI-modified1 . A method for decreasing incidence of mortality in a fowl, the method comprising:
(a) administering to the fowl an effective amount of a probiotic fowl supplement comprising:
(i) a Clostridium sp., and
(ii) a Clostridium cluster XIV bacterium; and
(b) a carrier suitable for fowl administration;
wherein the fowl administered the effective amount of the probiotic fowl supplement exhibits a decrease in the incidence of mortality, as compared to fowl not having been administered the supplement.
2 . The method of claim 1 , wherein the probiotic fowl supplement further comprises a Bacillus sp.
3 . The method of claim 1 , wherein the administering of the probiotic fowl supplement is an oral administration.
4 . The method of claim 3 , wherein the oral administration comprises combining the probiotic fowl supplement with the fowl's feed, water, litter, medicine, or vaccine; or spraying the fowl with the probiotic fowl supplement.
5 . The method of claim 1 , wherein the Clostridium sp. and/or the Clostridium cluster XIV bacterium are in spore form.
6 . The method of claim 1 , wherein the probiotic fowl supplement is administered to the fowl at least once a day.
7 . The method of claim 1 , wherein each administration of the probiotic fowl supplement comprises at least 10 3 of the Clostridium sp.
8 . The method of claim 1 , wherein the fowl is a broiler.
9 . The method of claim 1 , wherein (i) and/or (ii) are desiccated.
10 . The method of claim 9 , wherein (i) and/or (ii) are freeze dried.
11 . The method of claim 9 , wherein the probiotic fowl supplement has a moisture content of less than 10%.
12 . The method of claim 1 , wherein the probiotic fowl supplement is formulated as a water additive, a feed additive, a pre-pelleted feed additive, a pelleted feed additive, a post-pelleting-applied feed additive, a consumable liquid, a consumable solid, a consumable gel, or a gavage.
13 . The method of claim 12 , wherein the probiotic fowl supplement occurs within or on pelleted feed.
14 . The method of claim 1 , wherein the mortality is caused by a pathogen selected from: Mycoplasma gallisepticum, Mycoplasma meleagridis, Mycoplasma synoviae, Pasteurella multocida, Clostridium perfringens, Clostridium colinum, Clostridium botulinum, Salmonella typi, Salmonella typhimurium, Salmonella enterica, Salmonella pullorum, Salmonella gallinarum, Haemophilus gallinarum, Erysipelothrix insidiosa, Campylobacter jejuni, Campylobacter coli, Campylobacter lari, Listeria monocytogenes, Arcobacter butzleri, Mycobacterium avium , and pathogenic strains of Escherichia coli and Staphylococcus aureus.
15 . The method of claim 14 , wherein the mortality is caused by Clostridium perfringens.
16 . The method of claim 1 , wherein the incidence of mortality is decreased by at least 5%.
17 . The method of claim 1 , wherein the incidence of mortality is decreased by at least 10%.
18 . The method of claim 1 , wherein the administration of the probiotic fowl supplement shifts the non-pathogenic gut microbiome of the fowl.
19 . The method of claim 18 , wherein the gut microbiome shift is an increase in the relative abundance of one or more microbes that were present in the gut prior to administration of the probiotic fowl supplement.
20 . The method of claim 18 , wherein the gut microbiome shift is an increase in the relative abundance of obligate anaerobes and/or lactic acid-producing microbes.Join the waitlist — get patent alerts
Track US2019216863A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.